100 related articles for article (PubMed ID: 23528360)
1. Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitro.
Eibl JK; Strasser BC; Ross GM
Eur J Pharmacol; 2013 May; 708(1-3):30-7. PubMed ID: 23528360
[TBL] [Abstract][Full Text] [Related]
2. Using surface plasmon resonance spectroscopy to characterize the inhibition of NGF-p75(NTR) and proNGF-p75(NTR) interactions by small molecule inhibitors.
Sheffield KS; Vohra R; Scott JA; Ross GM
Pharmacol Res; 2016 Jan; 103():292-9. PubMed ID: 26675716
[TBL] [Abstract][Full Text] [Related]
3. Characterizing nerve growth factor-p75(NTR) interactions and small molecule inhibition using surface plasmon resonance spectroscopy.
Sheffield KS; Kennedy AE; Scott JA; Ross GM
Anal Biochem; 2016 Jan; 493():21-6. PubMed ID: 26435172
[TBL] [Abstract][Full Text] [Related]
4. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
Colquhoun A; Lawrance GM; Shamovsky IL; Riopelle RJ; Ross GM
J Pharmacol Exp Ther; 2004 Aug; 310(2):505-11. PubMed ID: 15051797
[TBL] [Abstract][Full Text] [Related]
5. Distinction between differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant delta9/13, which is selective for the p75 neurotrophin receptor.
Hughes AL; Messineo-Jones D; Lad SP; Neet KE
J Neurosci Res; 2001 Jan; 63(1):10-9. PubMed ID: 11169609
[TBL] [Abstract][Full Text] [Related]
6. NGF ligand alters NGF signaling via p75(NTR) and trkA.
Niederhauser O; Mangold M; Schubenel R; Kusznir EA; Schmidt D; Hertel C
J Neurosci Res; 2000 Aug; 61(3):263-72. PubMed ID: 10900073
[TBL] [Abstract][Full Text] [Related]
7. Methylmercury decreases NGF-induced TrkA autophosphorylation and neurite outgrowth in PC12 cells.
Parran DK; Barone S; Mundy WR
Brain Res Dev Brain Res; 2003 Mar; 141(1-2):71-81. PubMed ID: 12644250
[TBL] [Abstract][Full Text] [Related]
8. Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells.
Lachyankar MB; Condon PJ; Daou MC; De AK; Levine JB; Obermeier A; Ross AH
J Neurosci Res; 2003 Jan; 71(2):157-72. PubMed ID: 12503079
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor inhibitor with novel-binding domain demonstrates nanomolar efficacy in both cell-based and cell-free assay systems.
Kennedy AE; Laamanen CA; Ross MS; Vohra R; Boreham DR; Scott JA; Ross GM
Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971611
[TBL] [Abstract][Full Text] [Related]
10. Swedish Nerve Growth Factor Mutation (NGF
Sung K; Ferrari LF; Yang W; Chung C; Zhao X; Gu Y; Lin S; Zhang K; Cui B; Pearn ML; Maloney MT; Mobley WC; Levine JD; Wu C
J Neurosci; 2018 Apr; 38(14):3394-3413. PubMed ID: 29483280
[TBL] [Abstract][Full Text] [Related]
11. Kynurenic acid derivatives inhibit the binding of nerve growth factor (NGF) to the low-affinity p75 NGF receptor.
Jaen JC; Laborde E; Bucsh RA; Caprathe BW; Sorenson RJ; Fergus J; Spiegel K; Marks J; Dickerson MR; Davis RE
J Med Chem; 1995 Oct; 38(22):4439-45. PubMed ID: 7473570
[TBL] [Abstract][Full Text] [Related]
12. The p75 neurotrophin receptor enhances TrkA signalling by binding to Shc and augmenting its phosphorylation.
Epa WR; Markovska K; Barrett GL
J Neurochem; 2004 Apr; 89(2):344-53. PubMed ID: 15056278
[TBL] [Abstract][Full Text] [Related]
13. Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat.
Owolabi JB; Rizkalla G; Tehim A; Ross GM; Riopelle RJ; Kamboj R; Ossipov M; Bian D; Wegert S; Porreca F; Lee DK
J Pharmacol Exp Ther; 1999 Jun; 289(3):1271-6. PubMed ID: 10336516
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells.
Nishio M; Fukumoto S; Furukawa K; Ichimura A; Miyazaki H; Kusunoki S; Urano T; Furukawa K
J Biol Chem; 2004 Aug; 279(32):33368-78. PubMed ID: 15145933
[TBL] [Abstract][Full Text] [Related]
15. Generation of rationally-designed nerve growth factor (NGF) variants with receptor specificity.
Carleton LA; Chakravarthy R; van der Sloot AM; Mnich K; Serrano L; Samali A; Gorman AM
Biochem Biophys Res Commun; 2018 Jan; 495(1):700-705. PubMed ID: 29108999
[TBL] [Abstract][Full Text] [Related]
16. NGF activates the phosphorylation of MAP1B by GSK3beta through the TrkA receptor and not the p75(NTR) receptor.
Goold RG; Gordon-Weeks PR
J Neurochem; 2003 Nov; 87(4):935-46. PubMed ID: 14622124
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism.
Santos NA; Martins NM; Sisti FM; Fernandes LS; Ferreira RS; de Freitas O; Santos AC
Chem Biol Interact; 2017 Jan; 261():86-95. PubMed ID: 27871898
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of neuron survival during development by nerve growth factor binding to the p75 neurotrophin receptor.
Rydén M; Hempstead B; Ibáñez CF
J Biol Chem; 1997 Jun; 272(26):16322-8. PubMed ID: 9195937
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a distinctive motif of the low molecular weight neurotrophin receptor that modulates NGF-mediated neurite growth.
Dostaler SM; Ross GM; Myers SM; Weaver DF; Ananthanarayanan V; Riopelle RJ
Eur J Neurosci; 1996 May; 8(5):870-9. PubMed ID: 8743735
[TBL] [Abstract][Full Text] [Related]
20. Sciatic nerve conditioned medium depleted of pro-NGF modulates sodium currents and neurite outgrowth in PC12 cells.
Longart M; García L; Castillo C; Martínez JC; Medina R; Forsyth P; Malavé C
Neuroscience; 2009 Mar; 159(2):550-8. PubMed ID: 19171180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
